Click here if you are a Swedish investor looking for prospectus and information about listing on Nasdaq Stockholm

Director

Hjörleifur Pálsson

Mr. Palsson joined Alvotech’s Board of Directors at the Annual General Meeting held in June 2024. Since 2013 he has served as non-executive board member in sectors like pharmaceuticals, retail, medical devices, media & telecommunications, education and venture capital.

Mr. Palsson was the EVP/CFO of Ossur, a leading medical device company, listed on NASDAQ OMX Copenhagen, from 2001-2013, were he gained comprehensive experience in leading accounting, planning, investor relations, funding, corporate M&A, human resources, and business information services.

Prior, Mr. Palsson was a partner and a board member at Deloitte & Touche in Iceland where he practiced as a State Authorized Public Accountant from 1989 to 2001.

Mr. Palsson graduated with a Cand. Oecon degree in finance and accounting from the University of Iceland in 1988 and qualified as a State Authorized Public Accountant in 1989.